US2003130251A1PendingUtilityA1

Amino lactam sulfonamides as inhibitors of A-beta protein production

Priority: Oct 8, 1999Filed: Nov 4, 2002Published: Jul 10, 2003
Est. expiryOct 8, 2019(expired)· nominal 20-yr term from priority
C07D 409/14C07D 417/12C07D 243/10C07D 405/12C07D 409/12C07D 413/12C07D 401/12C07D 243/24A61P 25/28
47
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

This invention relates to novel lactams having the Formula (I): to their pharmaceutical compositions and to their methods of use. These novel compounds inhibit the processing of amyloid precursor protein and, more specifically, inhibit the production of Aβ-peptide, thereby acting to prevent the formation of neurological deposits of amyloid protein. More particularly, the present invention relates to the treatment of neurological disorders related to β-amyloid production such as Alzheimer's disease and Down's Syndrome.

Claims

exact text as granted — not AI-modified
What is claimed is:  
     
         1 . A compound of the Formula (I):  
       
         
           
           
               
               
           
         
       
       or a pharmaceutically acceptable salt or prodrug thereof, wherein: 
 Q is C 1 -C 6  alkyl substituted with 0-3 R 1a ; 
 C 3 -C 10  cycloalkyl substituted with 0-3 R 1b ;  
 C 3 -C 10  carbocycle substituted with 0-3 R 1b ;  
 C 6 -C 10  aryl substituted with 0-3 R 1b ; or  
 5 to 10 membered heterocycle containing 1 to 4 heteroatoms selected from nitrogen, oxygen, and sulphur, wherein said 5 to 10 membered heterocycle is substituted with 0-3 R 1b ;  
 
 R 1a , at each occurrence, is independently selected from H, R 1b , Cl, F, Br, I, OR 14 , CN, NO 2 , ═O, NR 19 R 20 , CF 3 , C 1 -C 4  alkyl; C 2 -C 4  alkenyl; C 2 -C 4  alkynyl; C 1 -C 4  haloalkyl; C 1 -C 4  haloalkoxy; 
 C 3 -C 10  carbocycle substituted with 0-3 R 1b ;  
 C 6 -C 10  aryl substituted with 0-3 R 1b ; and  
 5 to 10 membered heterocycle containing 1 to 4 heteroatoms selected from nitrogen, oxygen, and sulphur, wherein said 5 to 10 membered heterocycle is substituted with 0-3 R 1b ;  
 
 R 1b , at each occurrence, is independently selected from H, OR 14 , Cl, F, Br, I, CN, NO 2 , ═O, NR 19 R 20 , CF 3 , OCF 3 , C 1 -C 4  alkoxy, C 1 -C 4  haloalkoxy; 
 —C(═O)—R 1d , —O—R 1d , —S—R 1d , —S(═O)—R 1d , —S(═O) 2 —R 1d , —N(R 19 )—R 1d , —C(═O)NR 19b R 1d , NR 19b C(═O)—R 1d , —NR 19b S(═O) 2 —R 1d , —S(═O) 2 NR 19b —R 1d , —NR 19b S(═O)—R 1d , —S(═O)NR 19b —R 1d , —C(═O)O—R 1d , —OC(═O)—R 1d ;  
 C 1 -C 6  alkyl substituted with 0-3 R 1c ;  
 C 2 -C 6  alkenyl substituted with 0-2 R 1c ;  
 C 2 -C 6  alkynyl substituted with 0-2 R 1c ;  
 C 3 -C 10  cycloalkyl substituted with 0-3 R 1f ;  
 C 3 -C 10  carbocycle substituted with 0-3 R 1f ;  
 C 6 -C 10  aryl substituted with 0-3 R 1f ; and  
 5 to 14 membered heterocycle containing 1 to 4 heteroatoms selected from nitrogen, oxygen, and sulphur, wherein said 5 to 14 membered heterocycle is substituted with 0-3 R 1f ;  
 
 R 1c , at each occurrence, is independently selected from H, OR 14 , Cl, F, Br, I, CN, NO 2 , NR 19 R 20 , CF 3 , C 1 -C 4  alkoxy, C 1 -C 4  haloalkoxy; 
 —C(═O)—R 1d , —O—R 1d , —S—R 1d , —S(═O)—R 1d , —S(═O) 2 —R 1d , —N(R 19 )—R 1d , —C(═O)NR 19b R 1d , NR 19b C(═O)—R 1d , —NR 19b S(═O) 2 —R 1d , —S(═O) 2 NR 19b —R 1d , NR 19b s(═O)—R 1d , —S(═O)NR 19b —R 1d , —C(═O)O—R 1d , —OC(═O)—R 1d ;  
 C 3 -C 10  cycloalkyl substituted with 0-3 R 1f ;  
 C 3 -C 10  carbocycle substituted with 0-3 R 1f ;  
 C 6 -C 10  aryl substituted with 0-3 R 1f ; and  
 5 to 10 membered heterocycle containing 1 to 4 heteroatoms selected from nitrogen, oxygen, and sulphur, wherein said 5 to 10 membered heterocycle is substituted with 0-3 R 1f ;  
 
 R 1d , at each occurrence, is independently selected from H, 
 C 1 -C 6  alkyl substituted with 0-3 R 1e ;  
 C 2 -C 6  alkenyl substituted with 0-2 R 1e ;  
 C 2 -C 6  alkynyl substituted with 0-2 R 1e ;  
 C 3 -C 10  cycloalkyl substituted with 0-3 R 1f ;  
 C 3 -C 10  carbocycle substituted with 0-3 R 1f ;  
 C 6 -C 10  aryl substituted with 0-3 R 1f ; and  
 5 to 10 membered heterocycle containing 1 to 4 heteroatoms selected from nitrogen, oxygen, and sulphur, wherein said 5 to 10 membered heterocycle is substituted with 0-3 R 1f ;  
 
 R 1e , at each occurrence, is independently selected from H, OR 14 , Cl, F, Br, I, CN, NO 2 , ═O, NR 19 R 20 , CF 3 , C 1 -C 4  alkyl, C 1 -C 4  haloalkyl, C 1 -C 4  alkoxy, C 1 -C 4  haloalkoxy; 
 C 3 -C 10  cycloalkyl substituted with 0-3 R 1f ;  
 C 3 -C 10  carbocycle substituted with 0-3 R 1f ;  
 C 6 -C 10  aryl substituted with 0-3 R 1f ; and  
 5 to 10 membered heterocycle containing 1 to 4 heteroatoms selected from nitrogen, oxygen, and sulphur, wherein said 5 to 10 membered heterocycle is substituted with 0-3 R 1f ;  
 
 R 1f , at each occurrence, is independently selected from H, OR 14 , SR 14 , Cl, F, Br, I, CN, NO 2 , ═O, NR 19 R 20 , CF 3 , C 1 -C 4  alkyl, C 1 -C 4  haloalkyl, C 1 -C 4  alkoxy, C 1 -C 4  haloalkoxy, and C 1 -C 4  haloalkyl-S—;  
 R 2  is H, C 1 -C 6  alkyl, (C 1 -C 6  alkoxy) C 1 -C 3  alkyl, C 3 -C 6  carbocycle, C 6 -C 10  aryl, (C 3 -C 6  carbocycle)methyl, (C 6 -C 10  aryl)methyl, (C 6 -C 10  aryl)ethyl, or 5 to 10 membered heterocycle;  
 R 5  is H, OR 14 ; 
 C 1 -C 6  alkyl substituted with 0-3 R 5b ;  
 C 1 -C 6  alkoxy substituted with 0-3 R 5b ;  
 C 2 -C 6  alkenyl substituted with 0-3 R 5b ;  
 C 2 -C 6  alkynyl substituted with 0-3 R 5b ;  
 C 3 -C 10  cycloalkyl substituted with 0-3 R 5c ;  
 C 3 -C 10  carbocycle substituted with 0-3 R 5c ;  
 C 6 -C 10  aryl substituted with 0-3 R 5c ; or  
 5 to 10 membered heterocycle containing 1 to 4 heteroatoms selected from nitrogen, oxygen, and sulphur, wherein said 5 to 10 membered heterocycle is substituted with 0-3 R 5c ;  
 
 R 5a  is H or C 1 -C 4  alkyl;  
 R 5b , at each occurrence, is independently selected from: 
 H, C 1 -C 6  alkyl, CF 3 , OR 14 , Cl, F, Br, I, ═O, CN, NO 2 , NR 15 R 16 ; acetyl, —S(C 1 -C 4  alkyl), —S(═O)(C 1 -C 4  alkyl), —S(═O) 2 (C 1 -C 4  alkyl);  
 C 3 -C 10  cycloalkyl substituted with 0-3 R 5c ;  
 C 3 -C 10  carbocycle substituted with 0-3 R 5c ;  
 C 6 -C 10  aryl substituted with 0-3 R 5c ; and  
 5 to 10 membered heterocycle containing 1 to 4 heteroatoms selected from nitrogen, oxygen, and sulphur, wherein said 5 to 10 membered heterocycle is substituted with 0-3 R 5c ;  
 
 R 5c , at each occurrence, is independently selected from H, OH, Cl, F, Br, I, CN, NO 2 , NR 15 R 16 , CF 3 , acetyl, SCH 3 , S(═O)CH 3 , S(═O) 2 CH 3 , C 1 -C 6  alkyl, C 1 -C 4  alkoxy, C 1 -C 4  haloalkyl, C 1 -C 4  haloalkoxy, and C 1 -C 4  haloalkyl-S—;  
 R 6  is H; 
 C 1 -C 6  alkyl substituted with 0-3 R 6a ;  
 C 3 -C 10  carbocycle substituted with 0-3 R 6b ; or  
 C 6 -C 10  aryl substituted with 0-3 R 6b ;  
 
 R 6a , at each occurrence, is independently selected from H, C 1 -C 6  alkyl, OR 14 , Cl, F, Br, I, ═O, CN, NO 2 , NR 15 R 16 , aryl or CF 3 ;  
 R 6b , at each occurrence, is independently selected from H, OH, Cl, F, Br, I, CN, NO 2 , NR 15 R 16 , CF 3 , C 1 -C 6  alkyl, C 1 -C 4  alkoxy, C 1 -C 4  haloalkyl, and C 1 -C 4  haloalkoxy;  
 Ring B is a 6, 7, or 8 membered lactam, 
 wherein the lactam is saturated, partially saturated or unsaturated;  
 wherein each additional lactam carbon is substituted with 0-2 R 11 ; and,  
 optionally, the lactam contains a heteroatom selected from —N═, —NH—, —N(R 10 )—, —O—, —S—, —S(═O)—, and —S(═O) 2 —;  
 
 additionally, two R 11  substituents on adjacent atoms may be combined to form C 3 -C 6  carbocycle fused radical, a benzo fused radical, or a 5 to 6 membered heteroaryl fused radical, 
 wherein said 5 to 6 membered heteroaryl fused radical comprises 1-2 heteroatoms selected from N, O, and S;  
 wherein said benzo fused radical or 5 to 6 membered heteroaryl fused radical is substituted with 0-3 R 13 ;  
 
 R 10  is H, C(═O)R 17 , C(═O)OR 17 , C(═O)NR 18 R 19 , S(═O) 2 NR 18 R 19 , S(═O) 2 R 17 ; 
 C 1 -C 6  alkyl substituted with 0-2 R 10a ;  
 C 6 -C 10  aryl substituted with 0-4 R 10b ;  
 C 3 -C 10  carbocycle substituted with 0-3 R 10b ; or  
 5 to 10 membered heterocycle containing 1 to 4 heteroatoms selected from nitrogen, oxygen, and sulphur, wherein said 5 to 10 membered heterocycle is substituted with 0-3 R 10b ;  
 
 R 10a , at each occurrence, is independently selected from H, C 1 -C 6  alkyl, OR 14 , Cl, F, Br, I, ═O, CN, NO 2 , NR 15 R 16 , CF 3 , or aryl substituted with 0-4 R 10b ;  
 R 10b , at each occurrence, is independently selected from H, OH, C 1 -C 6  alkyl, C 1 -C 4  alkoxy, Cl, F, Br, I, CN, NO 2 , NR 15 R 16 , CF 3 , acetyl, SCH 3 , S(═O)CH 3 , S(═O) 2 CH 3 , C 1 -C 6  alkyl, C 1 -C 4  alkoxy, C 1 -C 4  haloalkyl, C 1 -C 4  haloalkoxy, and C 1 -C 4  haloalkyl-S—;  
 R 11 , at each occurrence, is independently selected from 
 H, C 1 -C 4  alkoxy, Cl, F, Br, I, ═O, CN, NO 2 , NR 18 R 19 , C(═O)R 17 , C(═O)OR 17 , C(═O)NR 18 R 19 , S(═O) 2 NR 18 R 19 , CF 3 ;  
 C 1 -C 6  alkyl substituted with 0-1 R 11a ;  
 C 6 -C 10  aryl substituted with 0-3 R 11b ;  
 C 3 -C 10  carbocycle substituted with 0-3 R 11b ; or  
 5 to 10 membered heterocycle containing 1 to 4 heteroatoms selected from nitrogen, oxygen, and sulphur, wherein said 5 to 10 membered heterocycle is substituted with 0-3 R 11b ;  
 
 R 11a , at each occurrence, is independently selected from H, C 1 -C 6  alkyl, OR 14 , Cl, F, Br, I, ═O, CN, NO 2 , NR 15 R 16 , CF 3 , or phenyl substituted with 0-3 R 11b ; 
 C 3 -C 10  carbocycle substituted with 0-3 R 11b ; or  
 5 to 10 membered heterocycle containing 1 to 4 heteroatoms selected from nitrogen, oxygen, and sulphur, wherein said 5 to 10 membered heterocycle is substituted with 0-3 R 11b ;  
 
 R 11b , at each occurrence, is independently selected from H, OH, Cl, F, Br, I, CN, NO 2 , NR 15 R 16 , CF 3 , acetyl, SCH 3 , S(═O)CH 3 , S(═O) 2 CH 3 , C 1 -C 6  alkyl, C 1 -C 4  alkoxy, C 1 -C 4  haloalkyl, C 1 -C 4  haloalkoxy, and C 1 -C 4  haloalkyl-S—;  
 W is —(CR 8 R 8a ) p —;  
 p is 0, 1, 2, 3, or 4;  
 R 8  and R 8a , at each occurrence, are independently selected from H, F, C 1 -C 4  alkyl, C 2 -C 4  alkenyl, C 2 -C 4  alkynyl and C 3 -C 8  cycloalkyl;  
 X is a bond; 
 C 6 -C 10  aryl substituted with 0-3 R Xb ;  
 C 3 -C 10  cycloalkyl substituted with 0-3 R Xb ;  
 C 3 -C 10  carbocycle substituted with 0-3 R Xb ; or  
 5 to 10 membered heterocycle containing 1 to 4 heteroatoms selected from nitrogen, oxygen, and sulphur, wherein said 5 to 10 membered heterocycle is substituted with 0-3 R Xb ;  
 
 R Xb , at each occurrence, is independently selected from H, OH, Cl, F, Br, I, CN, NO 2 , NR 15 R 16 , CF 3 , acetyl, SCH 3 , S(═O)CH 3 , S(═O) 2 CH 3 , C 1 -C 6  alkyl, C 1 -C 4  alkoxy, C 1 -C 4  haloalkyl, C 1 -C 4  haloalkoxy, and C 1 -C 4  haloalkyl-S—;  
 Y is a bond or —(CR 9 R 9a ) t —V—(CR 9 R 9a ) u —;  
 t is 0, 1, 2, or 3;  
 u is 0, 1, 2, or 3;  
 R 9  and R 9a , at each occurrence, are independently selected from H, F, C 1 -C 6  alkyl or C 3 -C 8  cycloalkyl;  
 V is a bond, —C(═O)—, —O—, —S—, —S(═O)—, —S(═O) 2 —, —N(R 19 )—, —C(═O)NR 19b —, —NR 19b C(═O)—, —NR 19b S(═O) 2 —, —S(═O) 2 NR 19b —, —NR 19b S(═O)—, —S(═O)NR 19b —, —C(═O)O—, or —OC(═O)—;  
 Z is H; 
 C 1 -C 8  alkyl substituted with 0-2 R 12 ;  
 C 2 -C 6  alkenyl substituted with 0-2 R 12 ;  
 C 2 -C 6  alkynyl substituted with 0-2 R 12 ;  
 C 6 -C 10  aryl substituted with 0-4 R 12b ;  
 C 3 -C 10  carbocycle substituted with 0-4 R 12b ; or  
 5 to 10 membered heterocycle containing 1 to 4 heteroatoms selected from nitrogen, oxygen, and sulphur, wherein said 5 to 10 membered heterocycle is substituted with 0-3 R 12b ;  
 
 R 12  is C 6 -C 10  aryl substituted with 0-4 R 12b ; 
 C 3 -C 10  carbocycle substituted with 0-4 R 12b ; or  
 5 to 10 membered heterocycle containing 1 to 4 heteroatoms selected from nitrogen, oxygen, and sulphur, wherein said 5 to 10 membered heterocycle is substituted with 0-3 R 12b ;  
 
 R 12b , at each occurrence, is independently selected from H, OH, Cl, F, Br, I, CN, NO 2 , NR 15 R 16 , CF 3 , acetyl, SCH 3 , S(═O)CH 3 , S(═O) 2 CH 3 , C 1 -C 6  alkyl, C 1 -C 4  alkoxy, C 1 -C 4  haloalkyl, C 1 -C 4  haloalkoxy, and C 1 -C 4  haloalkyl-S—;  
 R 13 , at each occurrence, is independently selected from H, OH, C 1 -C 6  alkyl, C 1 -C 4  alkoxy, Cl, F, Br, I, CN, NO 2 , NR 15 R 16 , or CF 3 ;  
 R 14 , at each occurrence, is independently selected from H, phenyl, benzyl, C 1 -C 6  alkyl, or C 2 -C 6  alkoxyalkyl;  
 R 15 , at each occurrence, is independently selected from H, C 1 -C 6  alkyl, phenyl, benzyl, phenethyl, —C(═O)—(C 1 -C 6  alkyl) and —S(═O) 2 —(C 1 -C 6  alkyl);  
 R 16 , at each occurrence, is independently selected from H, OH, C 1 -C 6  alkyl, phenyl, benzyl, phenethyl, —C(═O)—(C 1 -C 6  alkyl) and —S(═O) 2 —(C 1 -C 6  alkyl);  
 alternatively, —NR 15 R 16  may be a heterocyclic ring selected from the group piperidinyl, morpholinyl, thiomorpholinyl, pyrrolidinyl, homopiperidinyl, piperazinyl, and N-methylpiperizinyl;  
 R 17  is H, aryl, aryl-CH 2 —, C 1 -C 6  alkyl, or C 2 -C 6  alkoxyalkyl;  
 R 18 , at each occurrence, is independently selected from H, C 1 -C 6  alkyl, phenyl, benzyl, phenethyl, —C(═O)—(C 1 -C 6  alkyl) and —S(═O) 2 —(C 1 -C 6  alkyl);  
 R 19 , at each occurrence, is independently selected from H, OH, C 1 -C 6  alkyl, phenyl, benzyl, phenethyl, —C(═O)—(C 1 -C 6  alkyl) and —S(═O) 2 —(C 1 -C 6  alkyl);  
 R 19b , at each occurrence, is independently selected from H, C 1 -C 4  alkyl, phenyl, benzyl, and phenethyl; and  
 R 20  and R 21 , at each occurrence, are independently selected from H, C 1 -C 4  alkyl, aryl, and aryl(C 1 -C 2  alkyl)-;  
 provided that when Q is phenyl, 3-F-phenyl, benzyl, propyl, or octyl; R 2  is H; R 5  is methyl, and -WXYZ is methyl, then Ring B is not  
                     
  wherein R 13  is H.  
 
     
     
         2 . A compound of  claim 1 , or a pharmaceutically acceptable salt or prodrug thereof, wherein: 
 Q is C 1 -C 6  alkyl substituted with 0-3 R 1a ; 
 C 3 -C 10  cycloalkyl substituted with 0-3 R 1b ;  
 C 3 -C 10  carbocycle substituted with 0-3 R 1b ;  
 C 6 -C 10  aryl substituted with 0-3 R 1b ; or  
 5 to 10 membered heterocycle containing 1 to 4 heteroatoms selected from nitrogen, oxygen, and sulphur, wherein said 5 to 10 membered heterocycle is substituted with 0-3 R 1b ;  
   R 1a , at each occurrence, is independently selected from H, R 1b , Cl, F, Br, NR 19 R 20 , CF 3 , C 1 -C 4  alkyl, C 1 -C 4  haloalkyl; 
 C 3 -C 10  carbocycle substituted with 0-3 R 1b ;  
 C 6 -C 10  aryl substituted with 0-3 R 1b ; and  
 5 to 10 membered heterocycle containing 1 to 4 heteroatoms selected from nitrogen, oxygen, and sulphur, wherein said 5 to 10 membered heterocycle is substituted with 0-3 R 1b ;  
   R 1b , at each occurrence, is independently selected from H, OR 14 , Cl, F, Br, NO 2 , NR 19 R 20 , CF 3 , OCF 3 , C 1 -C 4  alkoxy, C 1 -C 4  haloalkoxy; 
 —C(═O)—R 1d , —O—R 1d , —S—R 1d , —S(═O)—R 1d , —S(═O) 2 —R 1d , —N(R 19 )—R 1d , —C(═O)NR 19b R 1d , —NR 19b C(═O)—R 1d , —NR 19b S(═O) 2 —R 1d , —S(═O) 2 NR 19b —R 1d , —NR 19b S(═O)—R 1d , —S(═O)NR 19b —R 1d , —C(═O)O—R 1d , —OC(═O)—R 1d ;  
 C 1 -C 6  alkyl substituted with 0-3 R 1c ;  
 C 3 -C 10  cycloalkyl substituted with 0-3 R 1f ;  
 C 6 -C 10  aryl substituted with 0-3 R 1f ; and  
 5 to 14 membered heterocycle containing 1 to 4 heteroatoms selected from nitrogen, oxygen, and sulphur, wherein said 5 to 14 membered heterocycle is substituted with 0-3 R 1f ;  
   R 1c , at each occurrence, is independently selected from H, OR 14 , Cl, F, Br, NO 2 , NR 19 R 20 , CF 3 , C 1 -C 4  alkoxy, C 1 -C 4  haloalkoxy; —C(═O)—R 1d , —O—R 1d , —S—R 1d , 
 —S(═O)—R 1d , —S(═O) 2 —R 1d , —N(R 19 )—R 1d , —C(═O)NR 19b R 1d , —NR 19b C(═O)—R 1d , —NR 19b S(═O) 2 —R 1d , —S(═O) 2 NR 19b —R 1d , —NR 19b S(═O)—R 1d , —S(═O)NR 19b —R 1d , —C(═O)O—R 1d , —OC(═O)—R 1d ;  
 C 3 -C 10  cycloalkyl substituted with 0-3 R 1f ;  
 C 3 -C 10  carbocycle substituted with 0-3 R 1f ;  
 C 6 -C 10  aryl substituted with 0-3 R 1f ; and  
 5 to 10 membered heterocycle containing 1 to 4 heteroatoms selected from nitrogen, oxygen, and sulphur, wherein said 5 to 10 membered heterocycle is substituted with 0-3 R 1f ;  
   R 1d , at each occurrence, is independently selected from H, C 1 -C 6  alkyl, and C 6 -C 10  aryl substituted with 0-3 R 1f ;    R 1f , at each occurrence, is independently selected from H, OR 14 , SR 14 , Cl, F, Br, I, CN, NO 2 , ═O, NR 19 R 20 , CF 3 , C 1 -C 4  alkyl, C 1 -C 4  haloalkyl, C 1 -C 4  alkoxy, C 1 -C 4  haloalkoxy, and C 1 -C 4  haloalkyl-S—;    R 2  is H or C 1 -C 6  alkyl;    R 5  is H, OR 14 ; 
 C 1 -C 6  alkyl substituted with 0-3 R 5b ;  
 C 1 -C 6  alkoxy substituted with 0-3 R 5b ;  
 C 2 -C 6  alkenyl substituted with 0-3 R 5b ; or  
 C 2 -C 6  alkynyl substituted with 0-3 R 5b ;  
   R 5a  is H or C 1 -C 4  alkyl;    R 5b , at each occurrence, is independently selected from: 
 H, C 1 -C 6  alkyl, CF 3 , OR 14 , Cl, F, Br, I, ═O, CN, NO 2 , NR 15 R 16 ; acetyl, S(C 1 -C 4  alkyl), S(═O)(C 1 -C 4  alkyl), S(═O) 2 (C 1 -C 4  alkyl),  
 C 3 -C 10  cycloalkyl substituted with 0-3 R 5c ;  
 C 3 -C 10  carbocycle substituted with 0-3 R 5c ;  
 C 6 -C 10  aryl substituted with 0-3 R 5c ; or  
 5 to 10 membered heterocycle containing 1 to 4 heteroatoms selected from nitrogen, oxygen, and sulphur, wherein said 5 to 10 membered heterocycle is substituted with 0-3 R 5c ;  
   R 5c , at each occurrence, is independently selected from H, OH, Cl, F, Br, I, CN, NO 2 , NR 15 R 16 , CF 3 , acetyl, SCH 3 , S(═O)CH 3 , S(═O) 2 CH 3 , C 1 -C 6  alkyl, C 1 -C 4  alkoxy, C 1 -C 4  haloalkyl, C 1 -C 4  haloalkoxy, and C 1 -C 4  haloalkyl-S—;    R 6  is H, methyl, or ethyl;    Ring B is a seven membered lactam, 
 wherein the lactam is saturated, partially saturated or unsaturated;  
 wherein each additional lactam carbon is substituted with 0-2 R 11 ; and,  
 optionally, the lactam contains a heteroatom selected from —N═, —NH—, —N(R 10 )—, —O—, —S—, —S(═O)—, and —S(═O) 2 —;  
   additionally, two R 11  substituents on adjacent atoms may be combined to form C 3 -C 6  carbocycle fused radical, a benzo fused radical, or a 5 to 6 membered heteroaryl fused radical, 
 wherein said 5 to 6 membered heteroaryl fused radical comprises 1-2 heteroatoms selected from N, O, and S;  
 wherein said benzo fused radical or 5 to 6 membered heteroaryl fused radical is substituted with 0-3 R 13 ;  
   R 10  is H, C(═O)R 17 , C(═O)OR 17 , C(═O)NR 18 R 19 , S(═O) 2 NR 18 R 19 , S(═O) 2 R 17 ; 
 C 1 -C 6  alkyl substituted with 0-2 R 10a ;  
 C 6 -C 10  aryl substituted with 0-4 R 10b ;  
 C 3 -C 10 carbocycle substituted with 0-3 R 10b ; or  
 5 to 10 membered heterocycle containing 1 to 4 heteroatoms selected from nitrogen, oxygen, and sulphur, wherein said 5 to 10 membered heterocycle is substituted with 0-3 R 10b ;  
   R 10a , at each occurrence, is independently selected from H, C 1 -C 6  alkyl, OR 14 , Cl, F, Br, I, ═O, CN, NO 2 , NR 15 R 16 , CF 3 , or aryl substituted with 0-4 R 10b ;    R 10b , at each occurrence, is independently selected from H, OH, C 1 -C 6  alkyl, C 1 -C 4  alkoxy, Cl, F, Br, I, CN, NO 2 , NR 15 R 16 , CF 3 , acetyl, SCH 3 , S(═O)CH 3 , S(═O) 2 CH 3 , C 1 -C 6  alkyl, C 1 -C 4  alkoxy, C 1 -C 4  haloalkyl, C 1 -C 4  haloalkoxy, and C 1 -C 4  haloalkyl-S—;    R 11 , at each occurrence, is independently selected from 
 H, C 1 -C 4  alkoxy, Cl, F, Br, I, ═O, CN, NO 2 , NR 18 R 19 , C(═O)R 17 , C(═O)OR 17 , C(═O)NR 18 R 19 , S(═O) 2 NR 18 R 19 , CF 3 ;  
 C 1 -C 6  alkyl substituted with 0-1 R 11a ;  
 C 6 -C 10  aryl substituted with 0-3 R 11b ;  
 C 3 -C 10  carbocycle substituted with 0-3 R 11b ; or  
 5 to 10 membered heterocycle containing 1 to 4 heteroatoms selected from nitrogen, oxygen, and sulphur, wherein said 5 to 10 membered heterocycle is substituted with 0-3 R 11b ;  
   R 11a , at each occurrence, is independently selected from H, C 1 -C 6  alkyl, OR 14 , Cl, F, Br, I, ═O, CN, NO 2 , NR 15 R 16 , CF 3 , or phenyl substituted with 0-3 R 11b ; 
 C 3 -C 10  carbocycle substituted with 0-3 R 11b ; or  
 5 to 10 membered heterocycle containing 1 to 4 heteroatoms selected from nitrogen, oxygen, and sulphur, wherein said 5 to 10 membered heterocycle is substituted with 0-3 R 11b ;  
   R 11b , at each occurrence, is independently selected from H, OH, Cl, F, Br, I, CN, NO 2 , NR 15 R 16 , CF 3 , acetyl, SCH 3 , S(═O)CH 3 , S(═O) 2 CH 3 , C 1 -C 6  alkyl, C 1 -C 4  alkoxy, C 1 -C 4  haloalkyl, C 1 -C 4  haloalkoxy, and C 1 -C 4  haloalkyl-S—;    W is —(CR 8 R 8a ) p —;    p is 0, 1, or 2;    R 8  and R 8a , at each occurrence, are independently selected from H, F, methyl, and ethyl;    X is a bond; 
 phenyl substituted with 0-3 R Xb ;  
 C 3 -C 6  cycloalkyl substituted with 0-3 R Xb ; or  
 5 to 6 membered heterocycle containing 1 to 4 heteroatoms selected from nitrogen, oxygen, and sulphur, wherein said 5 to 6 membered heterocycle is substituted with 0-2 R Xb ;  
   R Xb , at each occurrence, is independently selected from H, OH, Cl, F, Br, I, CN, NO 2 , NR 15 R 16 , CF 3 , acetyl, SCH 3 , S(═O)CH 3 , S(═O) 2 CH 3 , C 1 -C 6  alkyl, C 1 -C 4  alkoxy, C 1 -C 4  haloalkyl, C 1 -C 4  haloalkoxy, and C 1 -C 4  haloalkyl-S—;    Y is a bond or —(CR 9 R 9a ) t —V—(CR 9 R 9a ) u —;    t is 0, 1, or 2;    u is 0, 1, or 2;    R 9  and R 9a , at each occurrence, are independently selected from H, F, methyl, and ethyl;    V is a bond, —C(═O)—, —O—, —S—, —S(═O)—, —S(═O) 2 —, —N(R 19 )—, —NHC(═O)—, or —C(═O)NH—;    Z is H; 
 C 1 -C 6  alkyl substituted with 0-2 R 12 ;  
 C 2 -C 6  alkenyl substituted with 0-2 R 12 ;  
 C 2 -C 6  alkynyl substituted with 0-2 R 12 ;  
 phenyl substituted with 0-4 R 12b ;  
 C 3 -C 6  carbocycle substituted with 0-4 R 12b ; or  
 5 to 10 membered heterocycle containing 1 to 4 heteroatoms selected from nitrogen, oxygen, and sulphur, wherein said 5 to 10 membered heterocycle is substituted with 0-3 R 12b ;  
   R 12  is phenyl substituted with 0-4 R 12b ; 
 C 3 -C 6  carbocycle substituted with 0-4 R 12b ; or  
 5 to 10 membered heterocycle containing 1 to 4 heteroatoms selected from nitrogen, oxygen, and sulphur, wherein said 5 to 10 membered heterocycle is substituted with 0-3 R 12b ;  
   R 12b , at each occurrence, is independently selected from H, OH, Cl, F, Br, I, CN, NO 2 , NR 15 R 16 , CF 3 , acetyl, SCH 3 , S(═O)CH 3 , S(═O) 2 CH 3 , C 1 -C 6  alkyl, C 1 -C 4  alkoxy, C 1 -C 4  haloalkyl, C 1 -C 4  haloalkoxy, and C 1 -C 4  haloalkyl-S—;    R 13 , at each occurrence, is independently selected from H, OH, C 1 -C 4  alkyl, C 1 -C 4  alkoxy, Cl, F, Br, I, CN, NO 2 , NR 15 R 16 , and CF 3 ;    R 14 , at each occurrence, is independently selected from H, phenyl, benzyl, C 1 -C 6  alkyl, and C 2 -C 6  alkoxyalkyl;    R 15 , at each occurrence, is independently selected from H, C 1 -C 6  alkyl, phenyl, benzyl, phenethyl, —C(═O)—(C 1 -C 6  alkyl) and —S(═O) 2 —(C 1 -C 6  alkyl);    R 16 , at each occurrence, is independently selected from H, OH, C 1 -C 6  alkyl, phenyl, benzyl, phenethyl, —C(═O)—(C 1 -C 6  alkyl) and —S(═O) 2 —(C 1 -C 6  alkyl);    alternatively, —NR 15 R 16  may be a heterocyclic ring selected from the group piperidinyl, morpholinyl, thiomorpholinyl, pyrrolidinyl, homopiperidinyl, piperazinyl, and N-methylpiperizinyl;    R 17  is H, aryl, aryl-CH 2 —, C 1 -C 6  alkyl, or C 2 -C 6  alkoxyalkyl;    R 18 , at each occurrence, is independently selected from H, C 1 -C 6  alkyl, phenyl, benzyl, phenethyl, —C(═O)—(C 1 -C 6  alkyl) and —S(═O) 2 —(C 1 -C 6  alkyl);    R 19 , at each occurrence, is independently selected from H, OH, C 1 -C 6  alkyl, phenyl, benzyl, phenethyl, —C(═O)—(C 1 -C 6  alkyl) and —S(═O) 2 —(C 1 -C 6  alkyl); and    R 20  is H or C 1 -C 4 ;    provided that when Q is phenyl, 3-F-phenyl, benzyl, propyl, or octyl; R 2  is H; R 5  is methyl, and -WXYZ is methyl, then Ring B is not                           wherein R 13  is H.    
     
     
         3 . A compound of  claim 2  wherein Ring B is selected from:  
       
         
           
           
               
               
           
         
       
       wherein each benzo fused radical is substituted with 0-3 R 13 .  
     
     
         4 . A compound of  claim 3  of Formula (I):  
       
         
           
           
               
               
           
         
       
       or a pharmaceutically acceptable salt form or prodrug thereof, wherein: 
 Q is C 1 -C 6  alkyl substituted with 0-3 R 1a ; 
 C 3 -C 10  cycloalkyl substituted with 0-3 R 1b ;  
 C 6 -C 10  aryl substituted with 0-3 R 1b ; or  
 5 to 10 membered heterocycle containing 1 to 4 heteroatoms selected from nitrogen, oxygen, and sulphur, wherein said 5 to 10 membered heterocycle is substituted with 0-3 R 1b ;  
 
 R 1a , at each occurrence, is independently selected from H, Cl, F, Br, NR 19 R 20 , CF 3 , C 1 -C 4  alkyl; C 1 -C 4  haloalkyl; 
 C 6 -C 10  aryl substituted with 0-3 R 1b ; and  
 5 to 10 membered heterocycle containing 1 to 4 heteroatoms selected from nitrogen, oxygen, and sulphur, wherein said 5 to 10 membered heterocycle is substituted with 0-3 R 1b ;  
 
 R 1b , at each occurrence, is independently selected from H, OR 14 , Cl, F, Br, NO 2 , NR 19 R 20 , CF 3 , OCF 3 , C 1 -C 4  alkoxy, C 1 -C 4  haloalkoxy; 
 —C(═O)—R 1d , —OR 1d , —S—R 1d , —S(═O)—R 1d , —S(═O) 2 —R 1d , —N(R 19 )—R 1d , —C(═O)NR 19b R 1d , —NR 19b C(═O)—R 1d , —NR 19b S(═O) 2 —R 1d , —S(═O) 2 NR 19b —R 1d , —NR 19b S(═O)—R 1d , —S(═O)NR 19b —R 1d , —C(═O)O—R 1d , —OC(═O)—R 1d ;  
 C 1 -C 6  alkyl substituted with 0-3 R 1c ;  
 C 3 -C 10  cycloalkyl substituted with 0-3 R 1f ;  
 C 6 -C 10  aryl substituted with 0-3 R 1f ; and  
 5 to 14 membered heterocycle containing 1 to 4 heteroatoms selected from nitrogen, oxygen, and sulphur, wherein said 5 to 14 membered heterocycle is substituted with 0-3 R 1f ;  
 
 R 1c , at each occurrence, is independently selected from H, OR 14 , Cl, F, Br, NO 2 , NR 19 R 20 , CF 3 , C 1 -C 4  alkoxy, C 1 -C 4  haloalkoxy; —C(═O)—R 1d , —O—R 1d , —S—R 1d , —S(O)—R 1d , —S(═O) 2 —R 1d , —N(R 19 )—R 1d , —C(═O)NR 19b R 1d , —NR 19b C(═O)—R 1d , —NR 19b S(═O) 2 —R 1d , —S(═O) 2 NR 19b —R 1d , —NR 19b S(═O)—R 1d , —S(═O)NR 19b —R 1d , —C(═O)O—R 1d , —OC(═O)—R 1d ; 
 C 3 -C 10  cycloalkyl substituted with 0-3 R 1f ;  
 C 3 -C 10  carbocycle substituted with 0-3 R 1f ;  
 C 6 -C 10  aryl substituted with 0-3 R 1f ; and  
 5 to 10 membered heterocycle containing 1 to 4 heteroatoms selected from nitrogen, oxygen, and sulphur, wherein said 5 to 10 membered heterocycle is substituted with 0-3 R 1f ;  
 
 R 1d , at each occurrence, is independently selected from 
 H, C 1 -C 6  alkyl, and  
 C 6 -C 10  aryl substituted with 0-3 R 1f ;  
 
 R 1f , at each occurrence, is independently selected from 
 H, Cl, F, Br, NO 2 , CF 3 , C 1 -C 4  alkyl, C 1 -C 4  haloalkyl, C 1 -C 4  alkoxy, C 1 -C 4  haloalkoxy, and  
 C 1 -C 4  haloalkyl-S—;  
 
 R 2  is H, methyl, or ethyl;  
 R 5  is OR 14 ; 
 C 1 -C 6  alkyl substituted with 0-3 R 5b ;  
 C 1 -C 6  alkoxy substituted with 0-3 R 5b ;  
 C 2 -C 6  alkenyl substituted with 0-3 R 5b ; or  
 C 2 -C 6  alkynyl substituted with 0-3 R 5b ;  
 
 R 5a  is H or C 1 -C 4  alkyl;  
 R 5b , at each occurrence, is independently selected from: 
 H, C 1 -C 6  alkyl, CF 3 , OR 14 , Cl, F, Br, I, ═O, CN, NO 2 , NR 15 R 16 , acetyl, —S(C 1 -C 4  alkyl), S(═O)(C 1 -C 4  alkyl), S(═O) 2 (C 1 -C 4  alkyl);  
 C 3 -C 10  cycloalkyl substituted with 0-3 R 5c ;  
 C 6 -C 10  aryl substituted with 0-3 R 5c ; or  
 5 to 10 membered heterocycle containing 1 to 4 heteroatoms selected from nitrogen, oxygen, and sulphur, wherein said 5 to 10 membered heterocycle is substituted with 0-3 R 5c ;  
 
 R 5c , at each occurrence, is independently selected from H, OH, Cl, F, Br, I, CN, NO 2 , NR 15 R 16 , CF 3 , acetyl, SCH 3 , S(═O)CH 3 , S(═O) 2 CH 3 , C 1 -C 6  alkyl, C 1 -C 4  alkoxy, C 1 -C 4  haloalkyl, C 1 -C 4  haloalkoxy, and C 1 -C 4  haloalkyl-S—;  
 R 6  is H;  
 Ring B is selected from:  
                     
 R 11 , at each occurrence, is independently selected from 
 H, C 1 -C 4  alkoxy, Cl, F, Br, I, ═O, CN, NO 2 , NR 18 R 19 , C(═O)R 17 , C(═O)OR 17 , C(═O)NR 18 R 19 , S(═O) 2 NR 18 R 19 , CF 3 ;  
 C 1 -C 6  alkyl substituted with 0-1 R 11a ;  
 C 6 -C 10  aryl substituted with 0-3 R 11b ;  
 C 3 -C 10  carbocycle substituted with 0-3 R 11b ; or  
 5 to 10 membered heterocycle containing 1 to 4 heteroatoms selected from nitrogen, oxygen, and sulphur, wherein said 5 to 10 membered heterocycle is substituted with 0-3 R 11b ;  
 
 R 11a , at each occurrence, is independently selected from H, C 1 -C 6  alkyl, OR 14 , Cl, F, Br, I, ═O, CN, NO 2 , NR 15 R 16 , CF 3 , phenyl substituted with 0-3 R 11b ; 
 C 3 -C 10  carbocycle substituted with 0-3 R 11b ; or  
 5 to 10 membered heterocycle containing 1 to 4 heteroatoms selected from nitrogen, oxygen, and sulphur, wherein said 5 to 10 membered heterocycle is substituted with 0-3 R 11b ;  
 
 R 11b , at each occurrence, is independently selected from H, OH, Cl, F, Br, I, CN, NO 2 , NR 15 R 16 , CF 3 , acetyl, SCH 3 , S(═O)CH 3 , S(═O) 2 CH 3 , C 1 -C 6  alkyl, C 1 -C 4  alkoxy, C 1 -C 4  haloalkyl, C 1 -C 4  haloalkoxy, and C 1 -C 4  haloalkyl-S—;  
 W is —(CR 8 R 8a ) p —;  
 p is 0, 1, or 2;  
 R 8  and R 8a , at each occurrence, are independently selected from H, F, methyl, and ethyl;  
 X is a bond; 
 phenyl substituted with 0-3 R Xb ;  
 C 3 -C 6  cycloalkyl substituted with 0-3 R Xb ; or  
 5 to 6 membered heterocycle containing 1 to 4 heteroatoms selected from nitrogen, oxygen, and sulphur, wherein said 5 to 6 membered heterocycle is substituted with 0-2 R Xb ;  
 
 R Xb , at each occurrence, is independently selected from H, OH, Cl, F, Br, I, CN, NO 2 , NR 15 R 16 , CF 3 , acetyl, SCH 3 , S(═O)CH 3 , S(═O) 2 CH 3 , C 1 -C 6  alkyl, C 1 -C 4  alkoxy, C 1 -C 4  haloalkyl, C 1 -C 4  haloalkoxy, and C 1 -C 4  haloalkyl-S—;  
 Y is a bond or —(CR 9 R 9a ) t —V—(CR 9 R 9a ) u —;  
 t is 0, 1, or 2;  
 u is 0, 1, or 2;  
 R 9  and R 9a , at each occurrence, are independently selected from H, F, methyl, and ethyl;  
 V is a bond, —C(═O)—, —O—, —S—, —S(═O)—, —S(═O) 2 —, —N(R 19 )—, —C(═O)NH—, or —NHC(═O)—;  
 Z is H; 
 C 1 -C 6  alkyl substituted with 0-2 R 12 ;  
 C 2 -C 6  alkenyl substituted with 0-2 R 12 ;  
 C 2 -C 6  alkynyl substituted with 0-2 R 12 ;  
 phenyl substituted with 0-4 R 12b ;  
 C 3 -C 6  carbocycle substituted with 0-4 R 12b ; or  
 5 to 10 membered heterocycle containing 1 to 4 heteroatoms selected from nitrogen, oxygen, and sulphur, wherein said 5 to 10 membered heterocycle is substituted with 0-3 R 12b ;  
 
 R 12  is phenyl substituted with 0-4 R 12b ; 
 C 3 -C 6  carbocycle substituted with 0-4 R 12b ; or  
 5 to 10 membered heterocycle containing 1 to 4 heteroatoms selected from nitrogen, oxygen, and sulphur, wherein said 5 to 10 membered heterocycle is substituted with 0-3 R 12b ;  
 
 R 12b , at each occurrence, is independently selected from H, OH, Cl, F, Br, I, CN, NO 2 , NR 15 R 16 , CF 3 , acetyl, SCH 3 , S(═O)CH 3 , S(═O) 2 CH 3 , C 1 -C 6  alkyl, C 1 -C 4  alkoxy, C 1 -C 4  haloalkyl, C 1 -C 4  haloalkoxy, and C 1 -C 4  haloalkyl-S—;  
 R 13 , at each occurrence, is independently selected from H, OH, C 1 -C 4  alkyl, C 1 -C 4  alkoxy, Cl, F, Br, CN, NO 2 , and CF 3 ;  
 R 14 , at each occurrence, is independently selected from H, phenyl, benzyl, C 1 -C 6  alkyl, or C 2 -C 6  alkoxyalkyl;  
 R 15 , at each occurrence, is independently selected from H, C 1 -C 6  alkyl, phenyl, benzyl, phenethyl, —C(═O)—(C 1 -C 6  alkyl) and —S(═O) 2 —(C 1 -C 6  alkyl);  
 R 16 , at each occurrence, is independently selected from H, OH, C 1 -C 6  alkyl, phenyl, benzyl, phenethyl, —C(═O)—(C 1 -C 6  alkyl) and —S(═O) 2 —(C 1 -C 6  alkyl);  
 alternatively, —NR 15 R 16  may be a heterocyclic ring selected from the group piperidinyl, morpholinyl, thiomorpholinyl, pyrrolidinyl, homopiperidinyl, piperazinyl, and N-methylpiperizinyl;  
 R 17  is H, aryl, aryl-CH 2 —, C 1 -C 6  alkyl, or C 2 -C 6  alkoxyalkyl;  
 R 18 , at each occurrence, is independently selected from H, C 1 -C 6  alkyl, phenyl, benzyl, phenethyl, —C(═O)—(C 1 -C 6  alkyl) and —S(═O) 2 —(C 1 -C 6  alkyl);  
 R 19 , at each occurrence, is independently selected from H, OH, C 1 -C 6  alkyl, phenyl, benzyl, phenethyl, —C(═O)—(C 1 -C 6  alkyl) and —S(═O) 2 —(C 1 -C 6  alkyl); and  
 R 20  is H or C 1 -C 4 ;  
 provided that when Q is phenyl, 3-F-phenyl, benzyl, propyl, or octyl; R 2  is H; R 5  is methyl, and -WXYZ is methyl, then Ring B is not  
                     
  wherein R 13  is H.  
 
     
     
         5 . A compound of  claim 4  of Formula (Ia):  
       
         
           
           
               
               
           
         
       
       or a pharmaceutically acceptable salt form or prodrug thereof, wherein: 
 Ring B is  
                     
 Q is C 1 -C 6  alkyl substituted with 0-2 R 1a ; 
 C 6 -C 10  aryl substituted with 0-3 R 1b ; or  
 5 to 10 membered heterocycle containing 1 to 3 heteroatoms selected from nitrogen, oxygen, and sulphur, wherein said 5 to 10 membered heterocycle is substituted with 0-3 R 1b ;  
 
 R 1a , at each occurrence, is independently selected from H, Cl, F, Br, NR 19 R 20 , CF 3 , C 1 -C 4  alkyl, C 1 -C 4  haloalkyl, and phenyl substituted with 0-3 R 1b ;  
 R 1b , at each occurrence, is independently selected from H, OR 14 , Cl, F, Br, NO 2 , NR 19 R 20 , CF 3 , OCF 3 , C 1 -C 4  alkoxy, C 1 -C 4  haloalkoxy; —C(═O)—R 1d , —O—R 1d , —S(═O) 2 —R 1d , —N(R 19 )—R 1d , —C(═O)NR 19b R 1d , —NR 19b C(═O)—R 1d , —NR 19b S(═O) 2 —R 1d , —S(═O) 2 NR 19b —R 1d , C(═O)O—R 1d , —OC(═O)—R 1d ; 
 C 1 -C 6  alkyl substituted with 0-3 R 1c ;  
 C 6 -C 10  aryl substituted with 0-3 R 1f ; and  
 5 to 14 membered heterocycle containing 1 to 4 heteroatoms selected from nitrogen, oxygen, and sulphur, wherein said 5 to 14 membered heterocycle is substituted with 0-3 R 1f ;  
 
 R 1c , at each occurrence, is independently selected from H, —C(═O)—R 1d , —O—R 1d , —S—R 1d , —S(═O)—R 1d , —S(═O) 2 —R 1d , —N(R 19 )—R 1d , —C(═O)NR 19b R 1d , —NR 19b C(═O)—R 1d , —NR 19b S(═O) 2 —R 1d , —S(═O) 2 NR 19b —R 1d , —NR 19b S(═O)—R 1d , —S(═O)NR 19b —R 1d , —C(═O)O—R 1d , and —OC(═O)—R 1d ;  
 R 1d , at each occurrence, is independently selected from 
 H, C 1 -C 6  alkyl, and  
 C 6 -C 10  aryl substituted with 0-3 R 1f ;  
 
 R 1f , at each occurrence, is independently selected from H, Cl, F, Br, NO 2 , CF 3 , C 1 -C 4  alkyl, C 1 -C 4  haloalkyl, C 1 -C 4  alkoxy, C 1 -C 4  haloalkoxy, and C 1 -C 4  haloalkyl-S—;  
 R 5  is OR 14 ; 
 C 1 -C 6  alkyl substituted with 0-1 R 5b ;  
 C 2 -C 6  alkenyl substituted with 0-1 R 5b ; or  
 C 2 -C 6  alkynyl substituted with 0-1 R 5b ;  
 
 R 5a  is H or C 1 -C 4  alkyl;  
 R 5b , at each occurrence, is independently selected from: 
 H, methyl, ethyl, propyl, butyl, CF 3 , OR 14 , Cl, F, Br, I, ═O, CN, NO 2 , NR 15 R 16 ; acetyl, —S(C 1 -C 4  alkyl), —S(═O)(C 1 -C 4  alkyl), —S(═O) 2 (C 1 -C 4  alkyl),  
 C 3 -C 7  cycloalkyl substituted with 0-3 R 5c ;  
 phenyl substituted with 0-3 R 5c ; and  
 5 to 7 membered heterocycle containing 1 to 4 heteroatoms selected from nitrogen, oxygen, and sulphur, wherein said 5 to 7 membered heterocycle is substituted with 0-3 R 5c ;  
 
 R 5c , at each occurrence, is independently selected from H, OH, Cl, F, —NR 15 R 16 , CF 3 , acetyl, SCH 3 , S(═O) 2 CH 3 , methyl, ethyl, propyl, butyl, metrhoxy, ethoxy, propoxy, C 1 -C 2  haloalkyl, and C 1 -C 2  haloalkoxy;  
 R 11 , at each occurrence, is independently selected from 
 H, —NR 18 R 19 , —C(═O)R 17 , —C(═O)OR 17 , —C(═O)NR 18 R 19 , —S(═O) 2 NR 18 R 19 , —CF 3 ;  
 C 1 -C 6  alkyl substituted with 0-1 R 11a ;  
 phenyl substituted with 0-3 R 11b ;  
 C 3 -C 6  carbocycle substituted with 0-3 R 11b ; or  
 5 to 7 membered heterocycle containing 1 to 4 heteroatoms selected from nitrogen, oxygen, and sulphur, wherein said 5 to 7 membered heterocycle is substituted with 0-3 R 11b ;  
 
 R 11a , at each occurrence, is independently selected from H, C 1 -C 4  alkyl, OR 14 , Cl, F, Br, CN, NO 2 , NR 15 R 16 , CF 3 , phenyl substituted with 0-3 R 11b ; 
 C 3 -C 10  carbocycle substituted with 0-3 R 11b ; or  
 5 to 10 membered heterocycle containing 1 to 4 heteroatoms selected from nitrogen, oxygen, and sulphur, wherein said 5 to 10 membered heterocycle is substituted with 0-3 R 11b ;  
 
 R 11b , at each occurrence, is independently selected from H, OH, Cl, F, Br, I, CN, NO 2 , NR 15 R 16 , CF 3 , acetyl, SCH 3 , S(═O)CH 3 , S(═O) 2 CH 3 , C 1 -C 6  alkyl, C 1 -C 4  alkoxy, C 1 -C 4  haloalkyl, C 1 -C 4  haloalkoxy, and C 1 -C 4  haloalkyl-S—;  
 W is —(CR 8 R 8a ) p —;  
 p is 0, 1, or 2;  
 R 8  and R 8a , at each occurrence, are independently selected from H, F, methyl, and ethyl;  
 X is a bond; 
 phenyl substituted with 0-3 R Xb ;  
 C 3 -C 6  cycloalkyl substituted with 0-3 R Xb ; or  
 5 to 6 membered heterocycle containing 1 to 4 heteroatoms selected from nitrogen, oxygen, and sulphur, wherein said 5 to 6 membered heterocycle is substituted with 0-2 R Xb ;  
 
 R Xb , at each occurrence, is independently selected from H, OH, Cl, F, Br, I, CN, NO 2 , NR 15 R 16 , CF 3 , acetyl, SCH 3 , S(═O)CH 3 , S(═O) 2 CH 3 , C 1 -C 6  alkyl, C 1 -C 4  alkoxy, C 1 -C 4  haloalkyl, C 1 -C 4  haloalkoxy, and C 1 -C 4  haloalkyl-S—;  
 Y is a bond or —(CR 9 R 9a ) t —V—(CR 9 R 9a ) u —;  
 t is 0, 1, or 2;  
 u is 0, 1, or 2;  
 R 9  and R 9a , at each occurrence, are independently selected from H, F, methyl, and ethyl;  
 V is a bond, —C(═O)—, —O—, —S—, —S(═O)—, —S(═O) 2 —, —N(R 19 )—, —C(═O)NH—, or —NHC(═O)—;  
 Z is H; 
 C 1 -C 6  alkyl substituted with 0-2 R 12 ;  
 C 2 -C 6  alkenyl substituted with 0-2 R 12 ;  
 C 2 -C 6  alkynyl substituted with 0-2 R 12 ;  
 phenyl substituted with 0-4 R 12b ;  
 C 3 -C 6  carbocycle substituted with 0-4 R 12b ; or  
 5 to 10 membered heterocycle containing 1 to 4 heteroatoms selected from nitrogen, oxygen, and sulphur, wherein said 5 to 10 membered heterocycle is substituted with 0-3 R 12b ;  
 
 R 12  is phenyl substituted with 0-4 R 12b ; 
 C 3 -C 6  carbocycle substituted with 0-4 R 12b ; or  
 5 to 10 membered heterocycle containing 1 to 4 heteroatoms selected from nitrogen, oxygen, and sulphur, wherein said 5 to 10 membered heterocycle is substituted with 0-3 R 12b ;  
 
 R 12b , at each occurrence, is independently selected from H, OH, Cl, F, Br, I, CN, NO 2 , NR 15 R 16 , CF 3 , acetyl, SCH 3 , S(═O)CH 3 , S(═O) 2 CH 3 , C 1 -C 6  alkyl, C 1 -C 4  alkoxy, C 1 -C 4  haloalkyl, C 1 -C 4  haloalkoxy, and C 1 -C 4  haloalkyl-S—;  
 R 13 , at each occurrence, is independently selected from H, OH, C 1 -C 3  alkyl, C 1 -C 3  alkoxy, Cl, F, Br, CN, NO 2 , and CF 3 ;  
 R 14 , at each occurrence, is independently selected from H, phenyl, benzyl, C 1 -C 6  alkyl, and C 2 -C 6  alkoxyalkyl;  
 R 15 , at each occurrence, is independently selected from H, C 1 -C 6  alkyl, phenyl, benzyl, phenethyl, —C(═O)—(C 1 -C 6  alkyl) and —S(═O) 2 —(C 1 -C 6  alkyl);  
 R 16 , at each occurrence, is independently selected from H, OH, C 1 -C 6  alkyl, phenyl, benzyl, phenethyl, —C(═O)—(C 1 -C 6  alkyl) and —S(═O) 2 —(C 1 -C 6  alkyl);  
 alternatively, —NR 15 R 16  may be a heterocyclic ring selected from the group piperidinyl, morpholinyl, thiomorpholinyl, pyrrolidinyl, homopiperidinyl, piperazinyl, and N-methylpiperizinyl;  
 R 17  is H, phenyl, benzyl, C 1 -C 4  alkyl, or C 2 -C 4  alkoxyalkyl;  
 R 18 , at each occurrence, is independently selected from H, C 1 -C 6  alkyl, phenyl, benzyl, phenethyl, —C(═O)—(C 1 -C 6  alkyl) and —S(═O) 2 —(C 1 -C 6  alkyl);  
 R 19 , at each occurrence, is independently selected from H, OH, methyl, ethyl, propyl, butyl, phenyl, benzyl, and phenethyl; and  
 R 20  is H, methyl, ethyl, propyl, or butyl.  
 
     
     
         6 . A compound of  claim 5  of Formula (Ia) wherein: 
 Ring B is  
                     
 Q is C 1 -C 6  alkyl substituted with 0-1 R 1a ; 
 phenyl substituted with 0-3 R 1b ;  
 naphthyl substituted with 0-3 R 1b ; or  
 5 to 10 membered heterocycle containing 1 to 2 heteroatoms selected from nitrogen, oxygen, and sulphur, wherein said 5 to 10 membered heterocycle is substituted with 0-3 R 1b ;  
 
 R 1a , at each occurrence, is independently selected from 
 H, Cl, F, Br, —NR 19 R 20 , —CF 3 ; and  
 phenyl substituted with 0-3 R 1b ;  
 
 R 1b , at each occurrence, is independently selected from H, methyl, ethyl, OR 14 , Cl, F, Br, NO 2 , NR 19 R 20 , CF 3 , OCF 3 , C 1 -C 4  alkoxy, C 1 -C 4  haloalkoxy; 
 —C(═O)—R 1d , —O—R 1d , —S(═O) 2 —R 1d , —N(R 19 )—R 1d , —C(═O)NR 19b R 1d , —NR 19b C(═O)—R 1d , —NR 19b S(═O) 2 —R 1d , —S(═O) 2 NR 19b —R 1d , —C(═O)O—R 1d , —OC(═O)—R 1d ;  
 C 1 -C 6  alkyl substituted with 0-3 R 1c ;  
 phenyl substituted with 0-3 R 1f ; and  
 5 to 10 membered heterocycle containing 1 to 4 heteroatoms selected from nitrogen, oxygen, and sulphur, wherein said 5 to 10 membered heterocycle is substituted with 0-3 R 1f ;  
 
 R 1c , at each occurrence, is independently selected from H, —C(═O)—R 1d , —O—R 1d , —S—R 1d , —S(═O)—R 1d , —S(═O) 2 —R 1d , —N(R 19 )—R 1d , —C(═O)NR 19b R 1d , —NR 19b C(═O)—R 1d , —NR 19b S(═O) 2 —R 1d , and —S(═O) 2 NR 19b —R 1d ;  
 R 1d , at each occurrence, is independently selected from H, C 1 -C 6  alkyl; and phenyl substituted with 0-3 R 1f ;  
 R 1f , at each occurrence, is independently selected from H, Cl, F, Br, NO 2 , CF 3 , methyl, ethyl, propyl, methoxy, ethoxy, propoxy, C 1 -C 2  haloalkyl, and C 1 -C 2  haloalkoxy;  
 R 5  is OR 14  or C 1 -C 4  alkyl substituted with 0-1 R 5b ;  
 R 5a  is H;  
 R 5b , at each occurrence, is independently selected from: 
 H, methyl, ethyl, propyl, butyl, —NR 15 R 16 ;  
 C 3 -C 7  cycloalkyl substituted with 0-3 R 5c ;  
 phenyl substituted with 0-3 R 5c ; or  
 5 to 7 membered heterocycle containing 1 to 4 heteroatoms selected from nitrogen, oxygen, and sulphur, wherein said 5 to 7 membered heterocycle is substituted with 0-3 R 5c ; wherein said 5 to 7 membered heterocycle is selected from pyridinyl, pyrimidinyl, triazinyl, furanyl, thienyl, thiazolyl, pyrrolyl, piperazinyl, piperidinyl, homopiperidinyl, pyrazolyl, imidazolyl, oxazolyl, isoxazolyl, and tetrazolyl;  
 
 R 5c , at each occurrence, is independently selected from H, OH, Cl, F, —NR 15 R 16 , CF 3 , acetyl, SCH 3 , S(═O) 2 CH 3 , methyl, and methoxy;  
 R 11 , at each occurrence, is independently selected from 
 H, NR 18 R 19 , CF 3 ;  
 C 1 -C 6  alkyl substituted with 0-1 R 11a ;  
 phenyl substituted with 0-3 R 11b ;  
 C 3 -C 6  carbocycle substituted with 0-3 R 11b ; or  
 5 to 7 membered heterocycle containing 1 to 4 heteroatoms selected from nitrogen, oxygen, and sulphur, wherein said 5 to 7 membered heterocycle is substituted with 0-3 R 11b ; wherein said 5 to 7 membered heterocycle is selected from pyridinyl, pyrimidinyl, triazinyl, furanyl, thienyl, thiazolyl, pyrrolyl, piperazinyl, piperidinyl, homopiperidinyl, pyrazolyl, imidazolyl, oxazolyl, isoxazolyl, and tetrazolyl;  
 
 R 11a , at each occurrence, is independently selected from H, methyl, ethyl, propyl, butyl, methoxy, ethoxy, propoxy, Cl, F, Br, CN, NO 2 , NR 15 R 16 , CF 3 , phenyl substituted with 0-3 R 11b ; 
 C 3 -C 6  carbocycle substituted with 0-3 R 11b ; or  
 5 to 7 membered heterocycle containing 1 to 4 heteroatoms selected from nitrogen, oxygen, and sulphur, wherein said 5 to 7 membered heterocycle is substituted with 0-3 R 11b ; wherein said 5 to 7 membered heterocycle is selected from pyridinyl, pyrimidinyl, triazinyl, furanyl, thienyl, thiazolyl, pyrrolyl, piperazinyl, piperidinyl, homopiperidinyl, pyrazolyl, imidazolyl, oxazolyl, isoxazolyl, and tetrazolyl;  
 
 R 11b , at each occurrence, is independently selected from H, OH, Cl, F, NR 15 R 16 , CF 3 , acetyl, SCH 3 , S(═O)CH 3 , S(═O) 2 CH 3 , methyl, ethyl, propyl, butyl, methoxy, ethoxy, propoxy, C 1 -C 2  haloalkyl, and C 1 -C 2  haloalkoxy;  
 W is —(CHR 8 ) p —;  
 p is 0 or 1;  
 R 8  is H, methyl, or ethyl;  
 X is a bond; 
 phenyl substituted with 0-2 R Xb ;  
 C 3 -C 6  cycloalkyl substituted with 0-3 R Xb ; or  
 5 to 6 membered heterocycle containing 1 to 4 heteroatoms selected from nitrogen, oxygen, and sulphur, wherein said 5 to 6 membered heterocycle is substituted with 0-1 R Xb ;  
 
 R Xb , at each occurrence, is independently selected from H, OH, Cl, F, Br, I, CN, NO 2 , NR 15 R 16 , CF 3 , acetyl, SCH 3 , S(═O)CH 3 , S(═O) 2 CH 3 , C 1 -C 6  alkyl, C 1 -C 4  alkoxy, C 1 -C 4  haloalkyl, C 1 -C 4  haloalkoxy, and C 1 -C 4  haloalkyl-S—;  
 Y is a bond, —V—, —CH 2 —V—, —V—CH 2 —, or —CH 2 —V—CH 2 —;  
 V is a bond, —C(═O)—, —O—, —S—, —S(═O)—, —S(═O) 2 —, —N(R 19 )—, —C(═O)NH—, or —NHC(═O)—;  
 Z is H; 
 C 1 -C 6  alkyl substituted with 0-2 R 12 ;  
 C 2 -C 6  alkenyl substituted with 0-2 R 12 ;  
 C 2 -C 6  alkynyl substituted with 0-2 R 12 ;  
 phenyl substituted with 0-4 R 12b ;  
 C 3 -C 6  carbocycle substituted with 0-4 R 12b ; or  
 5 to 10 membered heterocycle containing 1 to 4 heteroatoms selected from nitrogen, oxygen, and sulphur, wherein said 5 to 10 membered heterocycle is substituted with 0-3 R 12b ;  
 
 R 12  is phenyl substituted with 0-4 R 12b ; 
 C 3 -C 6  carbocycle substituted with 0-4 R 12b ; or  
 5 to 10 membered heterocycle containing 1 to 4 heteroatoms selected from nitrogen, oxygen, and sulphur, wherein said 5 to 10 membered heterocycle is substituted with 0-3 R 12b ;  
 
 R 12b , at each occurrence, is independently selected from H, OH, Cl, F, Br, I, CN, NO 2 , NR 15 R 16 , CF 3 , acetyl, SCH 3 , S(═O)CH 3 , S(═O) 2 CH 3 , C 1 -C 6  alkyl, C 1 -C 4  alkoxy, C 1 -C 4  haloalkyl, C 1 -C 4  haloalkoxy, and C 1 -C 4  haloalkyl-S—;  
 R 13 , at each occurrence, is independently selected from H, methyl, ethyl, methoxy, ethoxy, Cl, F, Br, NO 2 , or CF 3 ;  
 R 14 , at each occurrence, is independently selected from H, phenyl, benzyl, C 1 -C 4  alkyl, or C 2 -C 4  alkoxyalkyl;  
 R 15 , at each occurrence, is independently selected from H, methyl, ethyl, propyl, butyl, phenyl, benzyl, and phenethyl;  
 R 16 , at each occurrence, is independently selected from H, OH, methyl, ethyl, propyl, butyl, phenyl, benzyl, phenethyl, CH 3 CH 2 C(═O)—, CH 3 C(═O)—, CH 3 CH 2 OC(═O)—, CH 3 OC(═O)—, CH 3 CH 2 S(═O) 2 — and CH 3 S(═O) 2 —;  
 R 18 , at each occurrence, is independently selected from H, methyl, ethyl, propyl, butyl, phenyl, benzyl, and phenethyl;  
 R 19 , at each occurrence, is independently selected from H, OH, methyl, ethyl, propyl, and butyl; and  
 R 20  is H, methyl, ethyl, propyl, or butyl.  
 
     
     
         7 . A compound of  claim 6  of Formula (Ia) wherein: 
 Ring B is  
                     
 Q is C 1 -C 4  alkyl substituted with 0-1 R 1a ; 
 phenyl substituted with 0-3 R 1b ;  
 naphthyl substituted with 0-3 R 1b ; or  
 5 to 10 membered heterocycle containing 1 to 2 heteroatoms selected from nitrogen, oxygen, and sulphur, wherein said 5 to 10 membered heterocycle is substituted with 0-3 R 1b ; wherein said 5 to 10 membered heterocycle is selected from pyridinyl, quinolinyl, pyrimidinyl, triazinyl, furanyl, thienyl, thiazolyl, imidazolyl, oxazolyl, and isoxazolyl;  
 
 R 1a , at each occurrence, is independently selected from 
 H, Cl, F, Br, CF 3 , and  
 phenyl substituted with 0-3 R 1b ;  
 
 R 1b , at each occurrence, is independently selected from H, methyl, ethyl, OR 14 , Cl, F, Br, NO 2 , NR 19 R 20 , CF 3 , OCF 3 , C 1 -C 4  alkoxy, C 1 -C 4  haloalkoxy; —C(═O)—R 1d , —O—R 1d , —S(═O) 2 —R 1d , —N(R 19 )—R 1d , —C(═O)NR 19b R 1d , —NR 19b C(═O)—R 1d , —NR 19b S(═O) 2 —R 1d , —S(═O) 2 NR 19b —R 1d , —C(═O)O—R 1d , —OC(═O)—R 1d ; 
 C 1 -C 6  alkyl substituted with 0-3 R 1c ;  
 phenyl substituted with 0-3 R 1f ; and  
 5 to 6 membered heterocycle containing 1 to 4 heteroatoms selected from nitrogen, oxygen, and sulphur, wherein said 5 to 6 membered heterocycle is substituted with 0-3 R 1f ;  
 
 R 1c , at each occurrence, is independently selected from H, —C(═O)—R 1d , —O—R 1d , —S—R 1d , —S(═O)—R 1d , —S(═O) 2 —R 1d , —N(R 19 )—R 1d , —C(═O)NR 19b R 1d , NR 19b C(═O)—R 1d , —NR 19b S(═O) 2 —R 1d , and —S(═O) 2 NR 19b —R 1d ,  
 R 1d , at each occurrence, is independently selected from H, C 1 -C 6  alkyl; and phenyl substituted with 0-3 R 1f ;  
 R 1f , at each occurrence, is independently selected from H, Cl, F, Br, NO 2 , CF 3 , —OCF 3 , methyl, ethyl, methoxy, and ethoxy;  
 R 5  is methyl substituted with 0-1 R 5b ; 
 ethyl substituted with 0-1 R 5b ;  
 propyl substituted with 0-1 R 5b ; or  
 butyl substituted with 0-1 R 5b ;  
 
 R 5a  is H;  
 R 5b , at each occurrence, is independently selected from: 
 H, methyl, ethyl, and NR 15 R 16 ;  
 
 R 11 , at each occurrence, is independently selected from H, NR 18 R 19 , CF 3 ; 
 C 1 -C 4  alkyl substituted with 0-1 R 11a ;  
 phenyl substituted with 0-3 R 11b ;  
 C 3 -C 6  carbocycle substituted with 0-3 R 11b ; or  
 5 to 7 membered heterocycle containing 1 to 4 heteroatoms selected from nitrogen, oxygen, and sulphur, wherein said 5 to 7 membered heterocycle is substituted with 0-3 R 11b ; wherein said 5 to 7 membered heterocycle is selected from pyridinyl, pyrimidinyl, triazinyl, furanyl, thienyl, thiazolyl, pyrrolyl, piperazinyl, piperidinyl, homopiperidinyl, pyrazolyl, imidazolyl, oxazolyl, isoxazolyl, and tetrazolyl;  
 
 R 11a , at each occurrence, is independently selected from H, methyl, ethyl, propyl, butyl, methoxy, ethoxy, propoxy, Cl, F, NR 15 R 16 , CF 3 ; 
 phenyl substituted with 0-3 R 11b ;  
 C 3 -C 6  carbocycle substituted with 0-3 R 11b ; or  
 5 to 7 membered heterocycle containing 1 to 4 heteroatoms selected from nitrogen, oxygen, and sulphur, wherein said 5 to 7 membered heterocycle is substituted with 0-3 R 11b ; wherein said 5 to 7 membered heterocycle is selected from pyridinyl, pyrimidinyl, triazinyl, furanyl, thienyl, thiazolyl, pyrrolyl, piperazinyl, piperidinyl, homopiperidinyl, pyrazolyl, imidazolyl, oxazolyl, isoxazolyl, and tetrazolyl;  
 
 R 11b , at each occurrence, is independently selected from H, OH, Cl, F, NR 15 R 16 , CF 3 , methyl, ethyl, propyl, methoxy, and ethoxy;  
 W is a bond, —CH 2 —, or —CH(CH 3 )—;  
 X is a bond; 
 phenyl substituted with 0-1 R Xb ;  
 C 3 -C 6  cycloalkyl substituted with 0-3 R Xb ; or  
 5 to 6 membered heterocycle containing 1 to 3 heteroatoms selected from nitrogen, oxygen, and sulphur; wherein said 5 to 6 membered heterocycle is selected from pyridinyl, pyrimidinyl, triazinyl, furanyl, thienyl, thiazolyl, pyrrolyl, piperazinyl, piperidinyl, pyrazolyl, imidazolyl, oxazolyl, and isoxazolyl;  
 
 Y is a bond, —V—, —CH 2 —V—, or —V—CH 2 —;  
 V is a bond, —C(═O)—, —O—, —S—, —S(═O)—, —S(═O) 2 —, —N(R 19 )—, —C(═O)NH—, or —NHC(═O)—;  
 Z is H; 
 C 1 -C 6  alkyl substituted with 0-2 R 12 ;  
 C 2 -C 6  alkenyl substituted with 0-2 R 12 ;  
 C 2 -C 6  alkynyl substituted with 0-2 R 12 ;  
 phenyl substituted with 0-4 R 12b ;  
 C 3 -C 6  carbocycle substituted with 0-4 R 12b ; or  
 5 to 10 membered heterocycle containing 1 to 4 heteroatoms selected from nitrogen, oxygen, and sulphur, wherein said 5 to 10 membered heterocycle is substituted with 0-3 R 12b ;  
 
 R 12  is phenyl substituted with 0-4 R 12b ; 
 C 3 -C 6  carbocycle substituted with 0-4 R 12b ; or  
 5 to 10 membered heterocycle containing 1 to 4 heteroatoms selected from nitrogen, oxygen, and sulphur, wherein said 5 to 10 membered heterocycle is substituted with 0-3 R 12b ;  
 
 R 12b , at each occurrence, is independently selected from H, OH, Cl, F, Br, NR 15 R 16 , CF 3 , OCF 3 , acetyl, SCH 3 , S(═O)CH 3 , S(═O) 2 CH 3 , methyl, ethyl, propyl, butyl, methoxy, ethoxy, propoxy, C 1 -C 2  haloalkyl, and C 1 -C 2  haloalkoxy;  
 R 13 , at each occurrence, is independently selected from H, methyl, methoxy, Cl, F, Br, and CF 3 ;  
 R 14 , at each occurrence, is independently selected from H, phenyl, benzyl, methyl, ethyl, propyl, and butyl;  
 R 15 , at each occurrence, is independently selected from H, methyl, ethyl, propyl, or butyl;  
 R 16 , at each occurrence, is independently selected from H, OH, methyl, ethyl, propyl, butyl, phenyl, benzyl, and phenethyl; 
 (3-Me-phenyl)CH 2 —, (4-Me-phenyl)CH 2 —, (2-MeS-phenyl)CH 2 —, (3-MeS-phenyl)CH 2 —, 4-MeS-phenyl)CH 2 —, (2-CF 3 O-phenyl)CH 2 —, (3-CF 3 O-phenyl)CH 2 —, (4-CF 3 O-phenyl)CH 2 —, (furanyl)CH 2 —, (thienyl)CH 2 —, (pyridyl)CH 2 —, (2-Me-pyridyl)CH 2 —, (3-Me-pyridyl)CH 2 —, (4-Me-pyridyl)CH 2 —, (1-imidazolyl)CH 2 —, (oxazolyl)CH 2 —, (isoxazolyl)CH 2 —, (1-benzimidazolyl)CH 2 —, morpholino)CH 2 —, (N-piperidinyl)CH 2 —, phenyl-CH 2 CH 2 —, (phenyl) 2 CHCH 2 —, (2-F-phenyl)CH 2 CH 2 —, (3-F-phenyl)CH 2 CH 2 —, (4-F-phenyl)CH 2 CH 2 —, (2-Cl-phenyl)CH 2 CH 2 —, (3-Cl-phenyl)CH 2 CH 2 —, (4-Cl-phenyl)CH 2 CH 2 —, (2,3-diF-phenyl)CH 2 CH 2 —, (2,4-diF-phenyl)CH 2 CH 2 —, (2,5-diF-phenyl)CH 2 CH 2 —, (2,6-diF-phenyl)CH 2 CH 2 —, (3,4-diF-phenyl)CH 2 CH 2 —, (3,5-diF-phenyl)CH 2 CH 2 —, (2,3-diCl-phenyl)CH 2 CH 2 —, (2,4-diCl-phenyl)CH 2 CH 2 —, (2,5-diCl-phenyl)CH 2 CH 2 —, (2,6-diCl-phenyl)CH 2 CH 2 —, (3,4-diCl-phenyl)CH 2 CH 2 —, (3,5-diCl-phenyl)CH 2 CH 2 —, (3-F-4-Cl-phenyl)CH 2 CH 2 —, (3-F-5-Cl-phenyl)CH 2 CH 2 —, (3-Cl-4-F-phenyl)CH 2 CH 2 —, (2-MeO-phenyl)CH 2 CH 2 —, (3-MeO-phenyl)CH 2 CH 2 —, (4-MeO-phenyl)CH 2 CH 2 —, (2-Me-phenyl)CH 2 CH 2 —, (3-Me-phenyl)CH 2 CH 2 —, (4-Me-phenyl)CH 2 CH 2 —, (2-MeS-phenyl)CH 2 CH 2 —, (3-MeS-phenyl)CH 2 CH 2 —, (4-MeS-phenyl)CH 2 CH 2 —, (2-CF 3 O-phenyl)CH 2 CH 2 —, (3-CF 3 O-phenyl)CH 2 CH 2 —, (4-CF 3 O-phenyl)CH 2 CH 2 —, (furanyl)CH 2 CH 2 —, (thienyl)CH 2 CH 2 —, (pyridyl)CH 2 CH 2 —, (2-Me-pyridyl)CH 2 CH 2 —, (3-Me-pyridyl)CH 2 CH 2 —, (4-Me-pyridyl)CH 2 CH 2 —, (imidazolyl)CH 2 CH 2 —, (oxazolyl)CH 2 CH 2 —, (isoxazolyl)CH 2 CH 2 —, (benzimidazolyl)CH 2 CH 2 —,(cyclopropyl)CH 2 CH 2 —, (cyclobutyl)CH 2 CH 2 —, (cyclopentyl)CH 2 CH 2 —, (cyclohexyl)CH 2 CH 2 —, (morpholino)CH 2 CH 2 —, or (N-piperidinyl)CH 2 CH 2 —;  
 
 R 11 , at each occurrence, is independently selected from H, methyl, ethyl, propyl, butyl, phenyl, benzyl, phenethyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cyclopropylmethyl, cyclobutylmethyl, cyclopentylmethyl, cyclohexylmethyl, cyclopropylethyl, cyclobutylethyl, cyclopentylethyl, cyclohexylethyl, 4-F-phenyl, 4-Cl-phenyl, 4-CH 3 -phenyl, 4-CF 3 -phenyl, 4-CH 3 O-phenyl, 4-CF 3 O-phenyl, 3-F-phenyl, 3-Cl-phenyl, 3-CH 3 -phenyl, 3-CF 3 -phenyl, 3-CH 3 O-phenyl, 3-CF 3 O-phenyl, 2-F-phenyl, 2-Cl-phenyl, 2-CH 3 -phenyl, 2-CF 3 -phenyl, 2-CH 3 O-phenyl, 2-CF 3 O-phenyl, (4-F-phenyl)methyl-, (4-Cl-phenyl)methyl-, 
 (4-CH 3 -phenyl)methyl-, (4-CF 3 -phenyl)methyl-, (4-CH 3 O-phenyl)methyl-, (4-CF 3 O-phenyl)methyl-, (3-F-phenyl)methyl-, (3-Cl-phenyl)methyl-, (3-CH 3 -phenyl)methyl-, (3-CF 3 -phenyl)methyl-, (3-CH 3 O-phenyl)methyl-, (3-CF 3 O-phenyl)methyl-, (2-F-phenyl)methyl-, (2-Cl-phenyl)methyl-, (2-CH 3 -phenyl)methyl-, (2-CF 3 -phenyl)methyl-, (2-CH 3 O-phenyl)methyl-, (2-CF 3 O-phenyl)methyl-, 2-pyridyl-, 3-pyridyl-, 4-pyridyl-, 1-piperidinyl, 1-homopiperidinyl, and 1-morpholino; and  
 
 R 13 , at each occurrence, is independently selected from H, F, Cl, and methoxy.  
 
     
     
         9 . A compound of  claim 7  wherein: 
 Q is —CH 3 , —CH 2 CH 3 , —CH 2 CH 2 CH 3 , —CH(CH 3 ) 2 , phenyl-, 2-F-phenyl-, 2-Cl-phenyl-, 2-Br-phenyl-, 2-NO 2 -phenyl-, 2-CH 3 -phenyl-, 2-CH 3 CH 2 -phenyl-, 2-CH 3 O-phenyl-, 2-CF 3 -phenyl-, 2-CF 3 O-phenyl-, 2-CH 3 CONH-phenyl, or 3,5-dimethyl-isoxazol-4-yl-;  
 R 5  is —CH 3 , —CH 2 CH 3 , —CH 2 CH 2 CH 3 , —CH(CH 3 ) 2 , —CH 2 CH 2 CH 2 CH 3 , —CH(CH 3 )CH 2 CH 3 , —CH 2 CH(CH 3 ) 2 , —CH 2 C(CH 3 ) 3 , —CH 2 CH 2 CH 2 CH 2 CH 3 , —CH(CH 3 )CH 2 CH 2 CH 3 , —CH 2 CH(CH 3 )CH 2 CH 3 , —CH 2 CH 2 CH(CH 3 ) 2 , —CH(CH 2 CH 3 ) 2 ,  
 W is a bond, —CH 2 —, or —CH(CH 3 )—;  
 X is a bond;  
                     
 Y is a bond, —CH 2 —V—, —V—, or —V—CH 2 —;  
 V is a bond, —C(═O)—, —O—, —S—, —S(═O)—, —S(═O) 2 —, —NH—, —N(CH 3 )—, —C(═O)NH—, or —NHC(═O)—,  
 Z is H, —CH 3 , —CH 2 CH 3 , —CH 2 CH 2 CH 3 , —CH(CH 3 ) 2 , —CH 2 CH 2 CH 2 CH 3 , —CH(CH 3 )CH 2 CH 3 , —CH 2 CH(CH 3 ) 2 , —C(CH 3 ) 3 , —CH 2 CH 2 CH 2 CH 2 CH 3 , —CH(CH 3 )CH 2 CH 2 CH 3 , —CH 2 CH(CH 3 )CH 2 CH 3 , —CH 2 CH 2 CH(CH 3 ) 2 , —CH(CH 2 CH 3 ) 2 , —CH 2 C(CH 3 ) 3 , —C(CH 3 ) 2 CH 2 CH 3 , 
 —CH(CH 3 )CH(CH 3 ) 2 , —CH 2 CH 2 CH 2 CH 2 CH 2 CH 3 , —CH(CH 3 )CH 2 CH 2 CH 2 CH 3 , —CH 2 CH(CH 3 )CH 2 CH 2 CH 3 , —CH 2 CH 2 CH(CH 3 )CH 2 CH 3 , —CH 2 CH 2 CH 2 CH(CH 3 ) 2 , —CH 2 CH(CH 2 CH 3 ) 2 ,  
 —CH 2 CH 2 C(CH 3 ) 3 , —CH(CH 2 CH 3 )CH 2 CH 2 CH 3 , —CF 3 , —CH 2 CF 3 , —CH 2 CH 2 CF 3 , —CH 2 CH 2 CH 2 CF 3 , —CH 2 CH 2 CH 2 CH 2 CF 3 ,  
 cyclopropyl-, (cyclopropyl)CH 2 —, (cyclopropyl)CH 2 CH 2 —, cyclobutyl-, (cyclobutyl)CH 2 —, (cyclobutyl)CH 2 CH 2 —, cyclopentyl-, (cyclopentyl)CH 2 —, (cyclopentyl)CH 2 CH 2 —, cyclohexyl-, (cyclohexyl)CH 2 —, (cyclohexyl)CH 2 CH 2 —, phenyl, 2-F-phenyl, 3-F-phenyl, 4-F-phenyl, 2-Cl-phenyl, 3-Cl-phenyl, 4-Cl-phenyl, 2,3-diF-phenyl, 2,4-diF-phenyl, 2,5-diF-phenyl, 2,6-diF-phenyl, 3,4-diF-phenyl, 3,5-diF-phenyl, 2,3-diCl-phenyl, 2,4-diCl-phenyl, 2,5-diCl-phenyl, 2,6-diCl-phenyl, 3,4-diCl-phenyl, 3,5-diCl-phenyl, 3-F-4-Cl-phenyl, 3-F-5-Cl-phenyl, 3-Cl-4-F-phenyl, 2-MeO-phenyl, 3-MeO-phenyl, 4-MeO-phenyl, 2-Me-phenyl, 3-Me-phenyl, 4-Me-phenyl, 2-MeS-phenyl, 3-MeS-phenyl, 4-MeS-phenyl, 2-CF 3 O-phenyl, 3-CF 3 O-phenyl, 4-CF 3 O-phenyl, furanyl, thienyl, pyridyl, 2-Me-pyridyl, 3-Me-pyridyl, 4-Me-pyridyl, 1-imidazolyl, oxazolyl, isoxazolyl, 1-benzimidazolyl, morpholino, N-piperidinyl, phenyl-CH 2 —, (2-F-phenyl)CH 2 —, (3-F-phenyl)CH 2 —, (4-F-phenyl)CH 2 —, (2-Cl-phenyl)CH 2 —, (3-Cl-phenyl)CH 2 —, (4-Cl-phenyl)CH 2 —, (2,3-diF-phenyl)CH 2 —, (2,4-diF-phenyl)CH 2 —, (2,5-diF-phenyl)CH 2 —, (2,6-diF-phenyl)CH 2 —, (3,4-diF-phenyl)CH 2 —, (3,5-diF-phenyl)CH 2 —, (2,3-diCl-phenyl)CH 2 —, (2,4-diCl-phenyl)CH 2 —, (2,5-diCl-phenyl)CH 2 —, (2,6-diCl-phenyl)CH 2 —, (3,4-diCl-phenyl)CH 2 —, (3,5-diCl-phenyl)CH 2 —, (3-F-4-Cl-phenyl)CH 2 —, (3-F-5-Cl-phenyl)CH 2 —, (3-Cl-4-F-phenyl)CH 2 —, (2-MeO-phenyl)CH 2 —, (3-MeO-phenyl)CH 2 —, (4-MeO-phenyl)CH 2 —, (2-Me-phenyl)CH 2 —, (3-Me-phenyl)CH 2 —, (4-Me-phenyl)CH 2 —, (2-MeS-phenyl)CH 2 —, (3-MeS-phenyl)CH 2 —, 4-MeS-phenyl)CH 2 —, (2-CF 3 O-phenyl)CH 2 —, (3-CF 3 O-phenyl)CH 2 —, (4-CF 3 O-phenyl)CH 2 —, (furanyl)CH 2 —, (thienyl)CH 2 —, (pyridyl)CH 2 —, (2-Me-pyridyl)CH 2 —, (3-Me-pyridyl)CH 2 —, (4-Me-pyridyl)CH 2 —, (1-imidazolyl)CH 2 —, (oxazolyl)CH 2 —, (isoxazolyl)CH 2 —, (1-benzimidazolyl)CH 2 —, morpholino)CH 2 —, (N-piperidinyl)CH 2 —, phenyl-CH 2 CH 2 —, (phenyl) 2 CHCH 2 —, (2-F-phenyl)CH 2 CH 2 —, (3-F-phenyl)CH 2 CH 2 —, (4-F-phenyl)CH 2 CH 2 —, (2-Cl-phenyl)CH 2 CH 2 —, (3-Cl-phenyl)CH 2 CH 2 —, (4-Cl-phenyl)CH 2 CH 2 —, (2,3-diF-phenyl)CH 2 CH 2 —, (2,4-diF-phenyl)CH 2 CH 2 —, (2,5-diF-phenyl)CH 2 CH 2 —, (2,6-diF-phenyl)CH 2 CH 2 —, (3,4-diF-phenyl)CH 2 CH 2 —, (3,5-diF-phenyl)CH 2 CH 2 —, (2,3-diCl-phenyl)CH 2 CH 2 —, (2,4-diCl-phenyl)CH 2 CH 2 —, (2,5-diCl-phenyl)CH 2 CH 2 —, (2,6-diCl-phenyl)CH 2 CH 2 —, (3,4-diCl-phenyl)CH 2 CH 2 —, (3,5-diCl-phenyl)CH 2 CH 2 —, (3-F-4-Cl-phenyl)CH 2 CH 2 —, (3-F-5-Cl-phenyl)CH 2 CH 2 —, (3-Cl-4-F-phenyl)CH 2 CH 2 —, (2-MeO-phenyl)CH 2 CH 2 —, (3-MeO-phenyl)CH 2 CH 2 —, (4-MeO-phenyl.)CH 2 CH 2 —, (2-Me-phenyl)CH 2 CH 2 —, (3-Me-phenyl)CH 2 CH 2 —, (4-Me-phenyl)CH 2 CH 2 —, (2-MeS-phenyl)CH 2 CH 2 —, (3-MeS-phenyl)CH 2 CH 2 —, (4-MeS-phenyl)CH 2 CH 2 —, (2-CF 3 O-phenyl)CH 2 CH 2 —, (3-CF 3 O-phenyl)CH 2 CH 2 —, (4-CF 3 O-phenyl)CH 2 CH 2 —, (furanyl)CH 2 CH 2 —, (thienyl)CH 2 CH 2 —, (pyridyl)CH 2 CH 2 —, (2-Me-pyridyl)CH 2 CH 2 —, (3-Me-pyridyl)CH 2 CH 2 —, (4-Me-pyridyl)CH 2 CH 2 —, (imidazolyl)CH 2 CH 2 —, (oxazolyl)CH 2 CH 2 —, (isoxazolyl)CH 2 CH 2 —, (benzimidazolyl)CH 2 CH 2 —, (cyclopropyl)CH 2 CH 2 —, (cyclobutyl)CH 2 CH 2 —, (cyclopentyl)CH 2 CH 2 —, (cyclohexyl)CH 2 CH 2 —, (morpholino)CH 2 CH 2 —, or (N-piperidinyl)CH 2 CH 2 —;  
 
 R 11 , at each occurrence, is independently selected from H, methyl, ethyl, propyl, butyl, phenyl, benzyl, phenethyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cyclopropylmethyl, cyclobutylmethyl, cyclopentylmethyl, cyclohexylmethyl, cyclopropylethyl, cyclobutylethyl, cyclopentylethyl, cyclohexylethyl, 4-F-phenyl, 4-Cl-phenyl, 4-CH 3 -phenyl, 4-CF 3 -phenyl, 4-CH 3 O-phenyl, 4-CF 3 O-phenyl, 3-F-phenyl, 3-Cl-phenyl, 3-CH 3 -phenyl, 3-CF 3 -phenyl, 3-CH 3 O-phenyl, 3-CF 3 O-phenyl, 2-F-phenyl, 2-Cl-phenyl, 2-CH 3 -phenyl, 2-CF 3 -phenyl, 2-CH 3 O-phenyl, 2-CF 3 O-phenyl, (4-F-phenyl)methyl-, (4-Cl-phenyl)methyl-, 
 (4-CH 3 -phenyl) methyl-, (4CF 3 -phenyl) methyl-, (4-CH 3 O-phenyl)methyl-, (4-CF 3 O-phenyl)methyl-, (3-F-phenyl)methyl-, (3-Cl-phenyl)methyl-, (3-CH 3 -phenyl)methyl-, (3-CF 3 -phenyl)methyl-, (3-CH 3 O-phenyl)methyl-, (3-CF 3 O-phenyl)methyl-, (2-F-phenyl)methyl-, (2-Cl-phenyl)methyl-, (2-CH 3 -phenyl)methyl-, (2-CF 3 -phenyl)methyl-, (2-CH 3 O-phenyl)methyl-, (2-CF 3 O-phenyl)methyl-, 2-pyridyl-, 3-pyridyl-, 4-pyridyl-, 1-piperidinyl, 1-homopiperidinyl, and 1-morpholino; and  
 
 R 13 , at each occurrence, is independently selected from H, F, Cl, and methoxy.  
 
     
     
         10 . A compound, according to  claim 1 , of Formula (Ic);  
       
         
           
           
               
               
           
         
       
       or a pharmaceutically acceptable salt form or prodrug thereof.  
     
     
         11 . A compound, according to  claim 1 , of Formula (Id);  
       
         
           
           
               
               
           
         
       
       or a pharmaceutically acceptable salt form or prodrug thereof.  
     
     
         12 . A compound, according to  claim 1 , of Formula (Ia):  
       
         
           
           
               
               
           
         
       
       or a pharmaceutically acceptable salt or prodrug thereof.  
     
     
         13 . A compound of  claim 1  wherein R 5  is OR 14 .  
     
     
         14 . A compound of  claim 1  wherein R 5  is C 1 -C 4  alkoxy substituted with 0-3 R 5b .  
     
     
         15 . A compound selected from: 
 2-(3,5-dimethyl-isoxazole-4-sulfonylamino)-4-methyl-pentanoic acid (1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-amide;    2-(3,5-dimethyl-isoxazole-4-sulfonylamino)-N-(1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-propionamide;    2-(3-bromo-5-chloro-thiophene-2-sulfonylamino)-4-methyl-pentanoic acid (1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-amide;    2-(naphthalene-1-sulfonylamino)-4-methyl-pentanoic acid (1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-amide;    2-(5-dimethylamino naphthalene-1-sulfonylamino)-4-methyl-pentanoic acid (1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-amide;    2-(naphthalene-2-sulfonylamino)-4-methyl-pentanoic acid (1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-amide;    2-(2-acetamido-4-methylthiazole-5-sulfonylamino)-4-methyl-pentanoic acid (1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-amide;    2-(thiophene-2-sulfonylamino)-4-methyl-pentanoic acid (1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-amide;    2-(quinoline-8-sulfonylamino)-4-methyl-pentanoic acid (1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-amide;    2-(phenyl-sulfonylamino)-4-methyl-pentanoic acid (1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-amide;    2-(2,5-dichlorophenyl sulfonylamino)-4-methyl-pentanoic acid (1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-amide;    2-(mesitylene-2-sulfonylamino)-4-methyl-pentanoic acid (1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-amide;    2-(3-nitrophenyl-sulfonylamino)-4-methyl-pentanoic acid (1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-amide;    2-(4-bromophenyl-sulfonylamino)-4-methyl-pentanoic acid (1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-amide;    2-(4-fluorophenyl-sulfonylamino)-4-methyl-pentanoic acid (1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-amide;    2-(4-chlorophenyl-sulfonylamino)-4-methyl-pentanoic acid (1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-amide;    2-(4-acetamidophenyl-sulfonylamino)-4-methyl-pentanoic acid (1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-amide;    2-(4-nitrophenyl-sulfonylamino)-4-methyl-pentanoic acid (1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-amide;    2-(4-methoxyphenyl-sulfonylamino)-4-methyl-pentanoic acid (1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-amide;    2-(4-tert-butylphenyl-sulfonylamino)-4-methyl-pentanoic acid (1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-amide;    2-(p-toluene-sulfonylamino)-4-methyl-pentanoic acid (1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-amide;    2-(benzyl-sulfonylamino)-4-methyl-pentanoic acid (1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-amide;    2-(beta-styrene-sulfonylamino)-4-methyl-pentanoic acid (1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-amide;    2-((2-methoxycarbonyl)phenyl-sulfonylamino)-4-methyl-pentanoic acid (1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-amide;    2-(2-nitro-4-(trifluoromethyl)phenyl-sulfonylamino)-4-methyl-pentanoic acid (1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-amide;    2-(3-(trifluoromethyl)phenyl-sulfonylamino)-4-methyl-pentanoic acid (1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-amide;    2-(2,5-dimethoxyphenyl-sulfonylamino)-4-methyl-pentanoic acid (1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-amide;    2-(2-methylphenyl-sulfonylamino)-4-methyl-pentanoic acid (1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-amide;    2-(3,4-dichlorophenyl-sulfonylamino)-4-methyl-pentanoic acid (1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-amide;    2-(4-(trifluoromethoxy)phenyl-sulfonylamino)-4-methyl-pentanoic acid (1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-amide;    2-(3,4-dimethoxyphenyl-sulfonylamino)-4-methyl-pentanoic acid (1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-amide;    2-(2-bromophenyl-sulfonylamino)-4-methyl-pentanoic acid (1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-amide;    2-(3,5-bis(trifluoromethyl)phenyl-2-sulfonylamino)-4-methyl-pentanoic acid (1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-amide;    2-(4-ethylphenyl-sulfonylamino)-4-methyl-pentanoic acid (1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-amide;    2-(4-isopropylphenyl-sulfonylamino)-4-methyl-pentanoic acid (1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-amide;    2-(2,5-dichlorothiophene-3-sulfonylamino)-4-methyl-pentanoic acid (1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-amide;    2-(5-chlorothiophene-2-sulfonylamino)-4-methyl-pentanoic acid (1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-amide;    2-(2-(trifluoromethyl)phenyl-sulfonylamino)-4-methyl-pentanoic acid (1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-amide;    2-(3-methylphenyl-sulfonylamino)-4-methyl-pentanoic acid (1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-amide;    2-(2,3-dichlorothiophene-5-sulfonylamino)-4-methyl-pentanoic acid (1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-amide;    2-(4-bromo-5-chlorothiophene-2-sulfonylamino)-4-methyl-pentanoic acid (1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-amide;    2-(5-[(benzoylamino)methyl]-thiophene-2-sulfonylamino)-4-methyl-pentanoic acid (1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-amide;    2-(4-phenylsulfonylthiophene-2-sulfonylamino)-4-methyl-pentanoic acid (1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-amide;    2-(5-(phenylsulfonyl)thiophene-2-sulfonylamino)-4-methyl-pentanoic acid (1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-amide;    2-[2-(1-methyl-(5-trifluoromethyl)pyrazole)thiophene-5-sulfonylamino]-4-methyl-pentanoic acid (1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-amide;    2-(5-(2-pyridyl)thiophene-2-sulfonylamino)-4-methyl-pentanoic acid (1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-amide;    2-2-(3,5-dimethyl-isoxazole-4-sulfonylamino)-4-methyl-pentanoic acid [5-(4-fluoro-phenyl)-1-methyl-2-oxo-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl]-amide;    N-[1-(3′-Chloro-4′-fluoro-biphenyl-3-ylmethyl)-2-oxo-azepan-3-yl]-2-(3,5-dimethyl-isoxazole-4-sulfonylamino)-propionamide;    2-(3,5-dimethyl-isoxazole-4-sulfonylamino)-N-[5-(4-fluoro-phenyl)-1-methyl-2-oxo-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl]-propionamide;    2-(2-fluoro-benzenesulfonylamino)-N-[5-(4-fluoro-phenyl)-1-methyl-2-oxo-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl]-propionamide;    N-(1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-2-(2-trifluoromethyl-benzenesulfonylamino)-propionamide;    2-(2-fluoro-benzenesulfonylamino)-4-methyl-pentanoic acid (1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-amide;    4-methyl-2-(2-trifluoromethyl-benzenesulfonylamino)-pentanoic acid (1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-amide;    4-methyl-2-(propane-1-sulfonylamino)-pentanoic acid (1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-amide;    4-methyl-2-(propane-1-sulfonylamino)-pentanoic acid (1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-amide;    2-(3,5-dimethyl-isoxazole-4-sulfonylamino)-N-[1-methyl-2-oxo-5-(4-trifluoromethyl-phenyl)-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl]-propionamide;    2-(3,5-dimethyl-isoxazole-4-sulfonylamino)-4-methyl-pentanoic acid (7-chloro-1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-amide;    4-methyl-2-(propane-1-sulfonylamino)-pentanoic acid [5-(4-chloro-phenyl)-1-methyl-2-oxo-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl]-amide;    2-(3,5-dimethyl-isoxazole-4-sulfonylamino)-4-methyl-pentanoic acid (1-methyl-2-oxo-5-pyridin-2-yl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-amide;    2-[(3,5-dimethyl-isoxazole-4-sulfonyl)-methyl-amino]-N-(1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-propionamide;    3-dimethylamino-2-(3,5-dimethyl-isoxazole-4-sulfonylamino)-N-(1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-propionamide;    N-[1-methyl-2-oxo-5-(4-trifluoromethyl-phenyl)-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl]-2-(propane-1-sulfonylamino)-propionamide;    N-(7-chloro-1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-2-(3,5-dimethyl-isoxazole-4-sulfonylamino)-propionamide;    2-(3,5-dimethyl-isoxazole-4-sulfonylamino)-4-methyl-pentanoic acid [5-(4-chloro-phenyl)-1-methyl-2-oxo-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl]-amide; and    2-methanesulfonylamino-N-[1-methyl-2-oxo-5-(4-trifluoromethyl-phenyl)-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl]-propionamide.    
     
     
         16 . A pharmaceutical composition comprising a compound of  claim 1  and a pharmaceutically acceptable carrier.  
     
     
         17 . A method for the treatment of neurological disorders comprising administering to a host in need of such treatment a therapeutically effective amount of a compound of  claim 1 .  
     
     
         18 . A method for the treatment of neurological disorders associated with Aβ amyloid production comprising administering to a host in need of such treatment a therapeutically effective amount of a compound of  claim 1 .  
     
     
         19 . A method for the treatment of Alzheimer's Disease comprising administering to a host in need of such treatment a therapeutically effective amount of a compound of  claim 1 .  
     
     
         20 . A method for the treatment of Alzheimer's Disease associated with Aβ amyloid production comprising administering to a host in need of such treatment a therapeutically effective amount of a compound of  claim 1 .  
     
     
         21 . A method for inhibiting γ-secretase activity comprising administering to a host in need of such inhibition a therapeutically effective amount of a compound of  claim 1  that inhibits γ-secretase activity.

Join the waitlist — get patent alerts

Track US2003130251A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.